Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR
Conditions
Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR
Trial Timeline
Dec 1, 2011 → May 1, 2012
NCT ID
NCT01526317About Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg) is a phase 1 stage product being developed by Yuhan for Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR. The current trial status is completed. This product is registered under clinical trial identifier NCT01526317. Target conditions include Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01526317 | Phase 1 | Completed |
Competing Products
20 competing products in Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR
Other Products from Yuhan
generic formulation of atorvastatin (Atorva®) + branded formulation of atorvastatin (Lipitor®)Approved
85
Pregabalin 150mg + Alpha-lipoic acid 480mg + Pregabalin 150mg + Alpha-Lipoic Acid 480mgApproved
85
Anplag Tab. 100mg bid + Anplag Tab. 100mg tidApproved
85
Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mg + Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mgApproved
85
Atorvastatin 20mg loading + Atorvastatin 80mg loadingApproved
85